• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冬凌草甲素类似物作为强效抗癌剂的设计与合成

Design and synthesis of novel oridonin analogues as potent anticancer agents.

作者信息

Shen Qing-Kun, Chen Zheng-Ai, Zhang Hong-Jian, Li Jia-Li, Liu Chuan-Feng, Gong Guo-Hua, Quan Zhe-Shan

机构信息

a Key Laboratory of Natural Resources and Functional Molecules of the Changbai Mountain, Affiliated Ministry of Education, College of Pharmacy , Yanbian University , Yanji , China.

b Department of Pharmacology , Medical School of Yanbian University , Yanji , China.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):324-333. doi: 10.1080/14756366.2017.1419219.

DOI:10.1080/14756366.2017.1419219
PMID:29303372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6054517/
Abstract

To identify anticancer agents with higher potency and lower toxicity, a series of oridonin derivatives with substituted benzene moieties at the C17 position were designed, synthesised, and evaluated for their antiproliferative properties. Most of the derivatives exhibited antiproliferative effects against AGS, MGC803, Bel7402, HCT116, A549, and HeLa cells. Compound 2p (IC= 1.05 µM) exhibited the most potent antiproliferative activity against HCT116 cells; it was more potent than oridonin (IC = 6.84 µM) and 5-fluorouracil (5-FU) (IC= 24.80 µM). The IC value of 2p in L02 cells was 6.5-fold higher than that in HCT116 cells. Overall, it exhibited better selective antiproliferative activity and specificity than oridonin and 5-FU. Furthermore, compound 2p arrested HCT116 cells at the G2 phase of the cell cycle and increased the percentage of apoptotic cells to a greater extent than oridonin.

摘要

为了鉴定具有更高效力和更低毒性的抗癌剂,设计、合成了一系列在C17位带有取代苯部分的冬凌草甲素衍生物,并对其抗增殖特性进行了评估。大多数衍生物对AGS、MGC803、Bel7402、HCT116、A549和HeLa细胞表现出抗增殖作用。化合物2p(IC=1.05μM)对HCT116细胞表现出最有效的抗增殖活性;它比冬凌草甲素(IC=6.84μM)和5-氟尿嘧啶(5-FU)(IC=24.80μM)更有效。2p在L02细胞中的IC值比在HCT116细胞中高6.5倍。总体而言,它比冬凌草甲素和5-FU表现出更好的选择性抗增殖活性和特异性。此外,化合物2p使HCT116细胞停滞在细胞周期的G2期,并且比冬凌草甲素更大程度地增加了凋亡细胞的百分比。

相似文献

1
Design and synthesis of novel oridonin analogues as potent anticancer agents.新型冬凌草甲素类似物作为强效抗癌剂的设计与合成
J Enzyme Inhib Med Chem. 2018 Dec;33(1):324-333. doi: 10.1080/14756366.2017.1419219.
2
Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.合成及体外和体内抗肿瘤活性评价 14-取代冬凌草甲素类似物:通过 p53-MDM2 通路诱导细胞周期停滞和凋亡的新型有效化合物。
Eur J Med Chem. 2019 Jul 1;173:15-31. doi: 10.1016/j.ejmech.2019.04.005. Epub 2019 Apr 6.
3
Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.新型含重氮-1-鎓-1,2-二醇盐一氧化氮供体部分的抗癌冬凌草甲素衍生物:设计、合成、生物学评价及一氧化氮释放研究
Bioorg Med Chem Lett. 2016 Jun 15;26(12):2795-2800. doi: 10.1016/j.bmcl.2016.04.068. Epub 2016 Apr 24.
4
Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.通过 Mizoroki-Heck 反应和点击化学合成冬凌草甲素衍生物及其细胞毒性。
Anticancer Agents Med Chem. 2019;19(7):935-947. doi: 10.2174/1871520619666190118121439.
5
Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria.用荧光类似物探究冬凌草甲素的抗癌作用:可视化其在线粒体中的亚细胞定位
J Med Chem. 2016 May 26;59(10):5022-34. doi: 10.1021/acs.jmedchem.6b00408. Epub 2016 Apr 27.
6
Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.新型济源冬凌草甲素 A-1,2,3-三唑-azole 衍生物的合成及生物评价作为抗增殖剂。
Eur J Med Chem. 2018 Sep 5;157:1249-1263. doi: 10.1016/j.ejmech.2018.08.056. Epub 2018 Aug 22.
7
Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.冬凌草甲素衍生物通过线粒体通路诱导肝癌细胞凋亡的潜在抗癌药物候选物。
Eur J Med Chem. 2019 Sep 15;178:365-379. doi: 10.1016/j.ejmech.2019.06.006. Epub 2019 Jun 4.
8
The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.奥多灵转化为螺内酯型或依美琴型二萜:新型潜在抗癌剂——ent-6,7-断键奥多灵衍生物的合成与生物评价。
Eur J Med Chem. 2012 Jun;52:242-50. doi: 10.1016/j.ejmech.2012.03.024. Epub 2012 Mar 23.
9
Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.硫化氢供体型贝壳杉烷和螺内酯型 6,7-裂贝壳杉烷衍生物的设计、合成及抗增殖活性。
Eur J Med Chem. 2019 Sep 15;178:446-457. doi: 10.1016/j.ejmech.2019.06.016. Epub 2019 Jun 6.
10
Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin.通过简化冬凌草甲素的核心结构和 14-羟基的修饰来鉴定新型有效的抗癌衍生物。
Eur J Med Chem. 2022 Mar 5;231:114155. doi: 10.1016/j.ejmech.2022.114155. Epub 2022 Jan 29.

引用本文的文献

1
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin.增强癌症治疗效果:用于冬凌草甲素的先进纳米载体递送系统
Front Pharmacol. 2024 Dec 3;15:1476739. doi: 10.3389/fphar.2024.1476739. eCollection 2024.
2
Oridonin from : An emerging potential in cancer therapy - A comprehensive review.冬凌草甲素的研究进展:癌症治疗中的新兴潜力——综述
Food Sci Nutr. 2024 Feb 1;12(5):3046-3067. doi: 10.1002/fsn3.3986. eCollection 2024 May.
3
Research and Development Progression of Oridonin for Hematological Malignancies Therapy.

本文引用的文献

1
Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.新型7-羟基-4-苯基色烯-2-酮与三唑部分连接作为强效细胞毒性剂的合成及生物学评价
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1111-1119. doi: 10.1080/14756366.2017.1344982.
2
Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.新型 1-(7-乙氧基-1-苯并呋喃-2-基)取代查尔酮衍生物的合成、表征及抗癌活性。
Eur J Med Chem. 2017 Aug 18;136:212-222. doi: 10.1016/j.ejmech.2017.05.017. Epub 2017 May 5.
3
A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway.
冬凌草甲素用于血液系统恶性肿瘤治疗的研发进展
Curr Med Chem. 2025;32(23):4713-4724. doi: 10.2174/0109298673273034231215190811.
4
Recent advances in oridonin derivatives with anticancer activity.具有抗癌活性的冬凌草甲素衍生物的最新进展
Front Chem. 2023 Feb 9;11:1066280. doi: 10.3389/fchem.2023.1066280. eCollection 2023.
5
Converting ginsenosides from stems and leaves of by microwave processing and improving their anticoagulant and anticancer activities.通过微波处理转化人参茎叶中的人参皂苷并提高其抗凝和抗癌活性。
RSC Adv. 2018 Dec 4;8(70):40471-40482. doi: 10.1039/c8ra08021f. eCollection 2018 Nov 28.
6
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.冬凌草甲素及其衍生物用于癌症治疗和克服治疗抗性。
Genes Dis. 2020 Jul 5;8(4):448-462. doi: 10.1016/j.gendis.2020.06.010. eCollection 2021 Jul.
7
Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells.冬凌草甲素通过A549细胞中AMPK/Akt/mTOR依赖性自噬体积累使顺铂诱导的细胞凋亡增敏。
Front Oncol. 2019 Aug 14;9:769. doi: 10.3389/fonc.2019.00769. eCollection 2019.
一种从天然冬凌草甲素骨架优化而来的新型强效抗癌化合物通过线粒体途径诱导细胞凋亡和细胞周期阻滞。
J Med Chem. 2017 Feb 23;60(4):1449-1468. doi: 10.1021/acs.jmedchem.6b01652. Epub 2017 Feb 13.
4
Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.新型3-取代4-苯胺基香豆素衍生物作为抗肿瘤剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2017 Feb 15;27(4):867-874. doi: 10.1016/j.bmcl.2017.01.013. Epub 2017 Jan 7.
5
Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer.具有体外协同抗癌活性的新型一氧化氮释放螺内酯型二萜衍生物作为凋亡诱导剂。
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4191-6. doi: 10.1016/j.bmcl.2016.07.059. Epub 2016 Jul 27.
6
Antitumor activities of biscoumarin and dihydropyran derivatives.双香豆素和二氢吡喃衍生物的抗肿瘤活性。
Bioorg Med Chem Lett. 2016 Aug 15;26(16):3876-80. doi: 10.1016/j.bmcl.2016.07.023. Epub 2016 Jul 9.
7
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.新型冬凌草甲素类似物CYD0682对肝纤维化的增强作用。
J Surg Res. 2015 Dec;199(2):441-9. doi: 10.1016/j.jss.2015.07.042. Epub 2015 Aug 5.
8
Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.新型冬凌草甲素衍生物CYD0692对肝星状细胞抗纤维化作用的增强
Mol Cell Biochem. 2015 Dec;410(1-2):293-300. doi: 10.1007/s11010-015-2562-4. Epub 2015 Sep 7.
9
Anti-cancer chalcones: Structural and molecular target perspectives.抗癌查耳酮:结构与分子靶点视角
Eur J Med Chem. 2015 Jun 15;98:69-114. doi: 10.1016/j.ejmech.2015.05.004. Epub 2015 May 14.
10
Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives.天然冬凌草甲素及其延命草素型衍生物的合成与抗分枝杆菌活性评价
Fitoterapia. 2014 Dec;99:300-6. doi: 10.1016/j.fitote.2014.10.005. Epub 2014 Oct 12.